Literature DB >> 20587424

Brain blood flow and velocity: correlations between magnetic resonance imaging and transcranial Doppler sonography.

Farzaneh A Sorond1, Norman K Hollenberg, Lawrence P Panych, Naomi D L Fisher.   

Abstract

OBJECTIVE: Because transcranial Doppler sonography (TCD) is unable to measure arterial diameter, it remains unproven whether the changes in cerebral blood velocity it measures are representative of changes in cerebral blood flow (CBF). Our study was designed to compare velocity changes with flow changes measured by two magnetic resonance imaging (MRI) techniques, perfusion MRI and arterial spin labeling (ASL), using flavanol-rich cocoa to induce CBF changes in healthy volunteers.
METHODS: We enrolled 20 healthy volunteers aged 62 to 80 years (mean, 73 years). Each was studied at baseline and after drinking standardized servings of cocoa for 7 to 14 days.
RESULTS: Changes in middle cerebral artery (MCA) flow by TCD were significantly correlated with changes in perfusion assessed by gadolinium-enhanced MRI (r = 0.63; P < .03). Measurements with ASL showed a stronger correlation with borderline significance.
CONCLUSIONS: Changes in flow velocity in the MCA associated with drinking cocoa were highly correlated with changes in CBF measured by the two MRI techniques using the tracer gadolinium and ASL. These results validate Doppler measurements of CBF velocity as representative assessments of CBF.

Entities:  

Mesh:

Year:  2010        PMID: 20587424      PMCID: PMC2906813          DOI: 10.7863/jum.2010.29.7.1017

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  23 in total

1.  Side-to-side differences and day-to-day variations of transcranial Doppler parameters in normal subjects.

Authors:  W Sorteberg; I A Langmoen; K F Lindegaard; H Nornes
Journal:  J Ultrasound Med       Date:  1990-07       Impact factor: 2.153

2.  Relationship of 133Xe cerebral blood flow to middle cerebral arterial flow velocity in men at rest.

Authors:  J M Clark; B E Skolnick; R Gelfand; R E Farber; M Stierheim; W C Stevens; G Beck; C J Lambertsen
Journal:  J Cereb Blood Flow Metab       Date:  1996-11       Impact factor: 6.200

3.  Cerebral blood flow autoregulation and transcranial Doppler sonography in patients with cirrhosis.

Authors:  F S Larsen; K S Olsen; E Ejlersen; B A Hansen; O B Paulson; G M Knudsen
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

4.  Simultaneous assessment of vasoreactivity using transcranial Doppler ultrasound and cerebral blood flow in healthy subjects.

Authors:  A Dahl; D Russell; R Nyberg-Hansen; K Rootwelt; P Mowinckel
Journal:  J Cereb Blood Flow Metab       Date:  1994-11       Impact factor: 6.200

5.  The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test-retest study.

Authors:  Esben Thade Petersen; Kim Mouridsen; Xavier Golay
Journal:  Neuroimage       Date:  2009-08-04       Impact factor: 6.556

Review 6.  Assessment of cerebral pressure autoregulation in humans--a review of measurement methods.

Authors:  R B Panerai
Journal:  Physiol Meas       Date:  1998-08       Impact factor: 2.833

7.  Comparison of static and dynamic cerebral autoregulation measurements.

Authors:  F P Tiecks; A M Lam; R Aaslid; D W Newell
Journal:  Stroke       Date:  1995-06       Impact factor: 7.914

8.  Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation.

Authors:  F S Larsen; K S Olsen; B A Hansen; O B Paulson; G M Knudsen
Journal:  Stroke       Date:  1994-10       Impact factor: 7.914

9.  Correlation of cerebral blood flow and MCA flow velocity measured in healthy volunteers during acetazolamide and CO2 stimulation.

Authors:  P T Ulrich; T Becker; O S Kempski
Journal:  J Neurol Sci       Date:  1995-04       Impact factor: 3.181

10.  Comparison of flow and velocity during dynamic autoregulation testing in humans.

Authors:  D W Newell; R Aaslid; A Lam; T S Mayberg; H R Winn
Journal:  Stroke       Date:  1994-04       Impact factor: 7.914

View more
  27 in total

Review 1.  The neuroprotective effects of cocoa flavanol and its influence on cognitive performance.

Authors:  Astrid Nehlig
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

2.  Reduced cerebral perfusion predicts greater depressive symptoms and cognitive dysfunction at a 1-year follow-up in patients with heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Naftali Raz; Lawrence H Sweet; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  Int J Geriatr Psychiatry       Date:  2013-09-10       Impact factor: 3.485

3.  Carotid artery stiffness and hemodynamic pulsatility during cognitive engagement in healthy adults: a pilot investigation.

Authors:  Kevin S Heffernan; Nicole L Spartano; Jacqueline A Augustine; Wesley K Lefferts; William E Hughes; Gary F Mitchell; Randall S Jorgensen; Brooks B Gump
Journal:  Am J Hypertens       Date:  2014-11-10       Impact factor: 2.689

4.  Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure.

Authors:  Julian Bösel; Jan C Purrucker; Frank Nowak; Julian Renzland; Petra Schiller; Eva Benveniste Pérez; Sven Poli; Benjamin Brunn; Werner Hacke; Thorsten Steiner
Journal:  Intensive Care Med       Date:  2012-10-25       Impact factor: 17.440

5.  Oral administration of the flavanol (-)-epicatechin bolsters endogenous protection against focal ischemia through the Nrf2 cytoprotective pathway.

Authors:  Christopher C Leonardo; Megha Agrawal; Nilendra Singh; J Russell Moore; Shyam Biswal; Sylvain Doré
Journal:  Eur J Neurosci       Date:  2013-09-23       Impact factor: 3.386

6.  Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults.

Authors:  Adam M Brickman; Usman A Khan; Frank A Provenzano; Lok-Kin Yeung; Wendy Suzuki; Hagen Schroeter; Melanie Wall; Richard P Sloan; Scott A Small
Journal:  Nat Neurosci       Date:  2014-10-26       Impact factor: 24.884

7.  Decreased physical activity predicts cognitive dysfunction and reduced cerebral blood flow in heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Naftali Raz; Lawrence H Sweet; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Neurol Sci       Date:  2014-02-18       Impact factor: 3.181

8.  Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Lawrence H Sweet; Richard Josephson; Joel Hughes; John Gunstad
Journal:  Pacing Clin Electrophysiol       Date:  2014-12-10       Impact factor: 1.976

9.  The interactive effects of cerebral perfusion and depression on cognitive function in older adults with heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Sarah Garcia; Richard Josephson; Manfred van Dulmen; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  Psychosom Med       Date:  2013-07-19       Impact factor: 4.312

10.  Middle cerebral artery blood flows by combining TCD velocities and MRA diameters: in vitro and in vivo validations.

Authors:  K A Yonan; E R Greene; J M Sharrar; A Caprihan; C Qualls; C A Roldan
Journal:  Ultrasound Med Biol       Date:  2014-09-11       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.